Quipt named to 2023 TSX Venture list
By HME News Staff
Updated 7:40 AM CST, Wed February 22, 2023
CINCINNATI – Quipt Home Medical has been named to the 2023 TSX Venture 50 for the Clean Tech & Life Sciences industry. The Venture 50 highlights top-performing companies from Canada and around the world that are driving growth across their respective sectors. There are more than 1,700 companies listed on the TSX Venture Exchange. “We are truly honored to have been selected for the TSX Venture 50, which marks the second time we have received this accolade in the previous four years,” said Greg Crawford, CEO. “This inclusion is a credit to the dedication of our team members and the ongoing support of our shareholders. Over the past year, several noteworthy accomplishments have been made, including the expansion of our robust patient-centric ecosystem and the achievement of sizable scale through accretive acquisitions and organic growth. These developments have all contributed to the company’s strong and reliable financial and operational performance. We are very enthusiastic about our growth prospects as 2023 gets underway, given our conservative balance sheet and pipeline of opportunities.” The TSX Venture 50 showcases issuers across five sectors with an equal weighting of each firm’s performance during 2022 across three key indicators: market capitalization growth, share price appreciation and trading volume.
Comments